CVS's Pharmacy Strategies Cut Drug Spending Growth To 5%
This article was originally published in Scrip
Executive Summary
CVS Health's efforts to control spending on prescription medicines provided valuable results in 2015, reducing growth in drug costs to 5% last year versus 11.8% in 2014 for customers served by the company's pharmacy benefit manager (PBM) CVS/Caremark.